Clinical Trials on Hepatitis A in United Kingdom

Total 2541 results

Perspectum
King's College London

Completed

Quantitative Magnetic Resonance Imaging to Aid Clinical Decision Making in Autoimmune Hepatitis.

Autoimmune Hepatitis

United Kingdom
King's College Hospital NHS Trust
Merck Sharp & Dohme LLC; Hepatitis C Trust

Terminated

ATTIC - Access To Treat in the Community (ATTIC)

Hepatitis C, Chronic

United Kingdom
Glasgow Royal Infirmary
Glasgow Caledonian University

Unknown

Re-engaging Patients With Hepatitis C Into Care

Hepatitis C, Chronic

United Kingdom
University College, London
Schering-Plough

Completed

The Role of Dendritic Cells in Hepatitis C Infection

Chronic Hepatitis C Infection

United Kingdom
Nottingham University Hospitals NHS Trust

Completed

Metformin Therapy in HCV Infection

Chronic Hepatitis C Infection

United Kingdom
Queen Mary University of London
LAPresearch UK

Unknown

Dynamic Liver Tests in Liver Disease

Hepatitis B | Hepatitis C

United Kingdom
NHS Tayside
University of Dundee

Completed

Ask a Friend to Take a Test for Hepatitis C Infection

Hepatitis C

United Kingdom
GlaxoSmithKline

Recruiting

Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection

Hepatitis B

United Kingdom
Mid and South Essex NHS Foundation Trust
Foundation for Liver Research

Recruiting

Immune Response in Patients With Hepatitis B and C Infection

Hepatitis B | Hepatitis C

United Kingdom
University of Dundee

Completed

Testing and Treating Hepatitis C in Community Pharmacies (SuperDOT-C)

Hepatitis C

United Kingdom
The Leeds Teaching Hospitals NHS Trust
Cancer Research UK

Completed

Hepatitis C Rimantadine and Antiviral Combination Therapy (HepRiACT)

Hepatitis C

United Kingdom
Presidio Pharmaceuticals, Inc.

Completed

A Phase 1a/1b Study of PPI-383 in Healthy Adults and Hepatitis C Patients

Hepatitis C, Chronic

United Kingdom, Mauritius
University of Surrey

Completed

A Study to Characterise Immune Responses Following Immunisations With "Fendrix" or "Engerix B" Hepatitis B Vaccines

Hepatitis B

United Kingdom
University of Dundee
NHS Tayside

Completed

A Self-efficAcy Intervention to reDuce Injecting Risk behAviour and hePatitis c reinfecTion Rates (ADAPT)

Hepatitis C

United Kingdom
University of Oxford

Completed

New Methods to Measure the Immune Response to Hepatitis B Vaccine

Hepatitis B

United Kingdom
University College, London
Central and North West London NHS Foundation Trust

Unknown

Sysmex-XN 20 Analyser to Assess Lymphocyte Subsets and Other Haematological Parameters in Chronic/Acute Viral Infections (SASA)

Chronic Hepatitis C | Diagnostic | Chronic HIV Infection | Chronic Viral Hepatitis B

United Kingdom
University of Birmingham
National Institute for Health Research, United Kingdom; University Hospital...

Completed

Pilot Study of Hepatitis C Virus Entry Inhibitor (ITX 5061) in Liver Transplant Recipients (ITX5061)

Hepatitis C | Evidence of Liver Transplantation

United Kingdom
ReiThera Srl
University of Oxford

Completed

A Study of a New Candidate Vaccine Against Hepatitis C Virus (HCV)

Hepatitis C

United Kingdom
ReiThera Srl
University of Oxford

Completed

Study of a Novel Therapeutic Vaccine for Hepatitis C Virus

Hepatitis C

United Kingdom
Pfizer

Completed

A Phase 1 Study Of PF-00868554 In Hepatitis C Virus (HCV) Positive Patients

Hepatitis C

Belgium, Germany, United Kingdom
University of Aberdeen
NHS Grampian

Completed

Changes in gUt micRobiota After Enteral Feeding (in Alcoholic Hepatitis) (CREED)

Alcoholic Hepatitis

United Kingdom
University of Dundee

Completed

Can Vitamin D Supplementation Improve Hepatitis C Cure Rates (ViaDUCT)

Hepatitis C

United Kingdom
Pennine Acute Hospitals NHS Trust
Roche Pharma AG

Unknown

Reinfection and Long Term Outcomes in Intravenous Drug Users (IVDUs) After Hepatitis C Treatment

Hepatitis C

United Kingdom
ReiThera Srl
University of Oxford; Oxford University Hospitals NHS Trust; University Hospital...

Completed

Study of a New MVA Vaccine for Hepatitis C Virus

Hepatitis C Infection

United Kingdom
Mid and South Essex NHS Foundation Trust

Recruiting

Immune Cell Dysfunction in Severe Alcoholic Hepatitis

Hepatitis

United Kingdom
King's College London

Unknown

Metabolic Surgery for Steato-Hepatitis (MeSH)

Non-alcoholic Fatty Liver Disease (NAFLD) | Non-Alcoholic Steato-Hepatitis (NASH)

United Kingdom
Vertex Pharmaceuticals Incorporated

Completed

Phase 2 Study of VX-950, Pegasys® With and Without Copegus® in Hepatitis C

Chronic Hepatitis C

Austria, France, Germany, United Kingdom
Imperial College London

Recruiting

N-ACetylcysteine to Reduce Infection and Mortality for Alcoholic Hepatitis (NACAH)

Infection | Alcoholic Hepatitis

United Kingdom
Novartis Pharmaceuticals

Completed

Pharmacokinetics and Safety of Single-Dose Telbivudine in Children and Adolescents With Chronic Hepatitis B

Chronic Hepatitis B

Belgium, Germany, United Kingdom, Philippines
GlaxoSmithKline

Active, not recruiting

A Mechanistic Study of GSK3228836 With Fine Needle Aspiration (FNA) in Participants With Chronic Hepatitis B (B-Fine)

Hepatitis B

United States, Netherlands, United Kingdom, Canada
F-star Therapeutics, Inc.
PRA Health Sciences

Terminated

Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic, Hepatitis B e Antigen-negative Subjects Infected With HBV Virus and Receiving or Stopping Treatment With a NUC Inhibitor

Hepatitis B | Hepatitis B, Chronic | HBV

Canada, United Kingdom
Tibotec BVBA

Completed

A Phase 2a Study to Evaluate Viral Kinetics and Safety of Telaprevir in Participants With Genotype 2 or 3 Hepatitis C Infection

Hepatitis C, Chronic

France, United Kingdom, Sweden
Sheffield Teaching Hospitals NHS Foundation Trust

Completed

A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Courses

Communicable Diseases | Hepatitis B | HIV | Infectious Diseases | HBV

United Kingdom
University Hospital Birmingham

Unknown

Alcohol Diet and Drug Use Preceding Alcoholic Hepatitis (ADDUP)

Hepatitis, Alcoholic

United Kingdom
GlaxoSmithKline

Recruiting

A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years

Hepatitis B

Germany, United Kingdom, Belgium
Vital Therapies, Inc.

Completed

Efficacy and Safety of the Extracorporeal Liver Assist Device (ELAD) in Acute on Chronic Hepatitis (SILVER)

Acute On Chronic Hepatitis

United States, United Kingdom
University of Oxford
Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Qidong... and other collaborators

Completed

Qidong Hepatitis B Intervention Study

Liver Diseases | Hepatitis B | Liver Neoplasms

United Kingdom, China
Gilead Sciences

Terminated

Utilization and Efficacy of Tenofovir DF in Adolescents With Chronic Hepatitis B Virus Infection

Hepatitis B

Spain, Italy, United Kingdom, Romania, Belgium, France, Greece
Grifols Therapeutics LLC

Completed

Anti-Hepatitis A Virus, Pharmacokinetics, and Safety of Immune Globulin (Human) (GamaSTAN)

Anti-Hepatitis A Antibody Levels in Heathy Subjects

United States
Gilead Sciences

Completed

Open Label Study of Pharmacokinetics and Safety of Dose of Adefovir Dipivoxil in Children and Adolescents With HBV

Hepatitis B

Belgium, Germany, Poland, United Kingdom
Altimmune, Inc.

Completed

Phase I Safety and Immunogenicity of FP-02.2 in Chronic Hepatitis B

Hepatitis B

Korea, Republic of, United Kingdom
Imperial College London

Completed

To Assess Neuroinflammation and Neurocognitive Function in Patients With Acute Hepatitis C and Chronic HIV Co-Infection

HIV Infections | HIV | Acute Hepatitis C

United Kingdom
Gilead Sciences

Terminated

Study to Investigate Pharmacokinetics, Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) Fixed Dose Combination (FDC) in Adolescents and Children With Chronic Hepatitis C Virus (HCV) Infection

Hepatitis C Virus Infection

Poland, Italy, United Kingdom
GlaxoSmithKline

Completed

Safety and Immunogenicity of 3 Lots of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Volunteers ≥ 15y

Hepatitis B

Australia, Czech Republic, Germany, Italy, Netherlands, Switzerland, United Kingdom
Novartis
Novartis Pharmaceuticals

Completed

A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis B

Chronic Hepatitis B

United States, United Kingdom, Spain, Korea, Republic of, Turkey, Thailand
Kirby Institute
AbbVie

Completed

Treatment of Recently Acquired Hepatitis C With the 3D Regimen or G/P (TARGET3D)

Hepatitis C, Acute

United Kingdom, Australia, New Zealand
Assembly Biosciences

Completed

Phase 1b/2a Study of ABI-H0731 in Patients With Chronic Hepatitis B

Chronic Hepatitis B

Korea, Republic of, Taiwan, Australia, Hong Kong, United Kingdom
Boehringer Ingelheim

Completed

BI 207127 / Faldaprevir Combination Therapy in Hepatic Impairment (Child-Pugh B) Patients With Genotype 1b Chronic Hepatitis C Infection: HCVerso3

Hepatitis C, Chronic

United States, Germany, Spain, United Kingdom
Hoffmann-La Roche

Terminated

Effect of RO7049665 on the Time to Relapse Following Steroid Tapering in Participants With Autoimmune Hepatitis (AIH)

Autoimmune Hepatitis | Autoimmune Chronic Hepatitis

Canada, United Kingdom, Korea, Republic of, Australia, Germany, Italy, Netherlands, Portugal
Alnylam Pharmaceuticals

Terminated

A Study of ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) Infection

Hepatitis B | Chronic Hepatitis B | Hepatitis B, Chronic | HBV | Hepatitis B Infection

United Kingdom, New Zealand, Singapore, Korea, Republic of, Australia, Hong Kong

Clinical Trials on Hepatitis A in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations